These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23031364)

  • 1. Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients.
    Colombo AA; Giorgiani G; Rognoni V; Villani P; Furione M; Bonora MR; Alessandrino EP; Zecca M; Baldanti F
    BMC Infect Dis; 2012 Oct; 12():238. PubMed ID: 23031364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
    Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation.
    Ke P; Bao X; Zhou J; Li X; Zhuang J; He X; Wu D; Zhang X; Ma X
    Hematology; 2020 Dec; 25(1):43-47. PubMed ID: 31906810
    [No Abstract]   [Full Text] [Related]  

  • 4. Human cytomegalovirus load measurement and its applications for pre-emptive therapy in patients undergoing hematopoietic stem cell transplantation.
    Baldanti F; Lilleri D; Gerna G
    Hematol Oncol; 2008 Sep; 26(3):123-30. PubMed ID: 18386849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
    Lilleri D; Gerna G; Fornara C; Chiesa A; Comolli G; Zecca M; Locatelli F
    J Infect Dis; 2009 Mar; 199(6):829-36. PubMed ID: 19239337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpesvirus infections in hematopoietic stem cell transplant recipients seropositive for human cytomegalovirus before transplantation.
    Fan J; Jing M; Yang M; Xu L; Liang H; Huang Y; Yang R; Gui G; Wang H; Gong S; Wang J; Zhang X; Zhao H; Gao H; Dong H; Ma W; Hu J
    Int J Infect Dis; 2016 May; 46():89-93. PubMed ID: 27057748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T; Dunne J; Crowley B
    J Med Virol; 2010 Mar; 82(3):433-40. PubMed ID: 20087937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation.
    Zhao XY; Pei XY; Chang YJ; Yu XX; Xu LP; Wang Y; Zhang XH; Liu KY; Huang XJ
    Clin Infect Dis; 2020 Mar; 70(7):1429-1437. PubMed ID: 31067570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
    Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
    Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.
    Gerna G; Lilleri D; Furione M; Castiglioni B; Meloni F; Rampino T; Agozzino M; Arbustini E
    New Microbiol; 2012 Jul; 35(3):279-87. PubMed ID: 22842597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
    Gerna G; Lilleri D; Zecca M; Alessandrino EP; Baldanti F; Revello MG; Locatelli F
    Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
    Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
    Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient.
    Arslan F; Tabak F; Avşar E; Midilli K; Mert A; Ozaras R; Soysal T; Ozturk R; Ferhanoglu B
    J Neurovirol; 2010 Mar; 16(2):174-8. PubMed ID: 20345320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial.
    Gerna G; Lilleri D; Baldanti F; Torsellini M; Giorgiani G; Zecca M; De Stefano P; Middeldorp J; Locatelli F; Revello MG
    Blood; 2003 Jun; 101(12):5053-60. PubMed ID: 12586622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
    Lilleri D; Gerna G; Zelini P; Chiesa A; Rognoni V; Mastronuzzi A; Giorgiani G; Zecca M; Locatelli F
    PLoS One; 2012; 7(7):e41648. PubMed ID: 22848556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring human cytomegalovirus infection in transplant recipients.
    Baldanti F; Lilleri D; Gerna G
    J Clin Virol; 2008 Mar; 41(3):237-41. PubMed ID: 18203657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HCMV infections after hematopoietic stem cell transplantation--diagnostic methods and importance of viral DNA level monitoring].
    Bocian J; Januszkiewicz-Lewandowska D
    Postepy Hig Med Dosw (Online); 2015 Feb; 69():252-63. PubMed ID: 25720612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.